Risk factors of primary thyroid dysfunction in early infants born to mothers with autoimmune thyroid disease

Junfen Fu1, Youjun Jiang, Li Liang

  • 1Department of Endocrinology, The Children's Hospital of Zhejiang University School of Medicine, Hangzhou, China. fjf68@yahoo.com.cn

Insights

Maternal autoimmune thyroid disease during pregnancy significantly impacts infant thyroid function. Careful management of these conditions is crucial to prevent adverse neonatal outcomes.

Area of Science:

  • Endocrinology
  • Neonatal Health
  • Immunology

Background:

  • Maternal thyroid dysfunction during pregnancy can pose risks to infant health.
  • Autoimmune thyroid diseases (AITD) like Graves' disease and Hashimoto thyroiditis are common in pregnant women.

Purpose of the Study:

  • To determine if maternal thyroid status and alterations during gestation affect infant thyroid function.
  • To identify risk factors for early infant thyroid dysfunction using logistic regression.

Main Methods:

  • A cross-sectional study involving 78 neonates born to mothers with AITD and a control group of neonates from healthy mothers.
  • Clinical and biochemical assessments of thyroid function, including antibody testing (TPOAb, TGAb, TRAb, TSAb) in mothers and infants.
  • Multiple logistic regression analysis to evaluate maternal and infant risk factors.

Main Results:

  • A high prevalence of subtle thyroid abnormalities (52.6%) was observed in infants of mothers with AITD, significantly higher than controls (0.54%).
  • Maternal thyroid function during gestation, type of AITD, and neonatal TRAb levels were significantly correlated with infant thyroid dysfunction.

Conclusions:

  • Maternal autoimmune thyroid disease during pregnancy adversely affects infant thyroid function.
  • Effective management of maternal AITD throughout pregnancy is vital for preventing negative neonatal outcomes.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...